Susan Fitzpatrick
InvestorInterim Board Chair at FACIT (Fight Against Cancer Innovation Trust)
About
Head of the Canadian Drug Agency Transition Office at Health Canada and former inaugural CEO of Ontario Health, with over three decades of leadership across Canada's health care and life sciences sectors.
Colleagues at FACIT (Fight Against Cancer Innovation Trust)
Connie Chen
Senior Director, Strategy and Corporate Development at FACIT (Fight Against Cancer Innovation Trust)
David Koehler
Director, Fund Operations at FACIT (Fight Against Cancer Innovation Trust)
David O'Neill
President at FACIT (Fight Against Cancer Innovation Trust)
Elizabeth Douville
Investment Committee Chair at FACIT (Fight Against Cancer Innovation Trust)
Enrico D'Angelo
CFO at Parkwalk Advisors
Francesca Chappell
Chief Finance Officer at BP Marsh & Partners PLC
Kelly Holman
Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)
Ken Newport
Board Director at FACIT (Fight Against Cancer Innovation Trust)
Frequently asked questions
- Who is Susan Fitzpatrick?
- Head of the Canadian Drug Agency Transition Office at Health Canada and former inaugural CEO of Ontario Health, with over three decades of leadership across Canada's health care and life sciences sectors.
- Where does Susan Fitzpatrick work?
- Susan Fitzpatrick is Interim Board Chair at FACIT (Fight Against Cancer Innovation Trust).



